Matthew Goff Investment Advisor’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
IWS
Matthew Goff Investment Advisor's IHE Position: Q2 2026 in Review
Matthew Goff Investment Advisor held its iShares US Pharmaceuticals ETF (IHE) position steady in Q2 2026 at 3,615 shares worth $358K. The position accounts for 0.06% of the portfolio, ranked #82.
Matthew Goff Investment Advisor first reported a position in IHE in Q2 2018 and has held it in 24 quarters since. The position peaked at $678K in Q2 2018. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.
- Matthew Goff Investment Advisor held 3,615 shares of iShares US Pharmaceuticals ETF worth $358K as of Q2 2026.
- Matthew Goff Investment Advisor left its iShares US Pharmaceuticals ETF share count unchanged in Q2 2026.
- iShares US Pharmaceuticals ETF made up 0.06% of Matthew Goff Investment Advisor's portfolio in Q2 2026, its #82 holding.
- Matthew Goff Investment Advisor first reported a position in iShares US Pharmaceuticals ETF in Q2 2018 and has held it in 24 quarters since.
- Matthew Goff Investment Advisor's iShares US Pharmaceuticals ETF position peaked at $678K in Q2 2018.
- 209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.
Based on Matthew Goff Investment Advisor's 13F filing for Q2 2026, filed 8 Jul 2026.